Reduction of galectin-3 expression and liver fibrosis after cell therapy in a mouse model of cirrhosis

References

• Corrao G, Arico S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology. 1998;27:914–19.
   PubMed Web of Science ®Google Scholar
• Keeffe EB. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology. 2001;120: 749–62.
   PubMed Web of Science ®Google Scholar
• Tsui JI, Pletcher MJ, Vittinghoff E, Seal K, Gonzales R. Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems. J Hepatol. 2006;44:262–6.
   PubMed Web of Science ®Google Scholar
• Dranoff JA, Wells RG. Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology. 2010;51:1438–44.
   PubMed Web of Science ®Google Scholar
• Forbes SJ, Parola M. Liver fibrogenic cells. Best Pract Res Clin Gastroenterol. 2011;25:207–17.
   PubMed Web of Science ®Google Scholar
• Sasaki S, Bao Q, Hughes RC. Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1. 1 antibodies. J Pathol. 1999;187:481–9.
   PubMed Web of Science ®Google Scholar
• Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, . Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA. 2006;103:5060–5.
   PubMed Web of Science ®Google Scholar
• Maeda N, Kawada N, Seki S, Arakawa T, Ikeda K, . Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways. J Biol Cem. 2003;278:18938–44.
   Google Scholar
• Higashiyama R, Moro T, Nakao S, Mikami K, . Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology. 2009:137:1459–66.
   PubMed Web of Science ®Google Scholar
• Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115: 209–18.
   PubMed Web of Science ®Google Scholar
• Neuberger J. Liver transplantation. J Hepatol. 2000;32:198–207.
   PubMedGoogle Scholar
• Mimeault M, Hauke R, Batra SK. Stem cells: a revolution in therapeutics – recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther. 2007;82:252–64.
   PubMed Web of Science ®Google Scholar
• Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, . Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229–34.
   PubMed Web of Science ®Google Scholar
• Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, . Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol. 2006;44:742–8.
   PubMed Web of Science ®Google Scholar
• Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature. 2003;422:901–4.
   PubMed Web of Science ®Google Scholar
• Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol. 2004;6:532–9.
   PubMed Web of Science ®Google Scholar
• Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076–84.
   PubMed Web of Science ®Google Scholar
• Fang B, Shi M, Liao L, Yang S, Liu Y, . Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation. 2004;78:83–8.
   PubMed Web of Science ®Google Scholar
• Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, . Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology. 2004;40:1304–11.
   PubMed Web of Science ®Google Scholar
• Zhao DC, Lei JX, Chen R, Yu WH, Zhang XM, . Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol. 2005;11:3431–40.
   PubMed Web of Science ®Google Scholar
• Higashiyama R, Inagaki Y, Hong YY, Kushida M, Nakao S, . Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology. 2007;45:213–22.
   PubMed Web of Science ®Google Scholar
• Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, . G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol. 2005;33:108–19.
   PubMed Web of Science ®Google Scholar
• Di Campli C, Piscaglia AC, Pierelli L, Rutella S, Bonanno G, . A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. Dig Liver Dis. 2004;36:603–13.
   PubMedGoogle Scholar
• Tang XP, Yang X, Tan H, Ding YL, Zhang M, . Clinical and experimental study on the therapeutic effect of umbilical cord blood transplantation on severe viral hepatitis. World J Gastroenterol. 2003;9:1999–2003.
   PubMedGoogle Scholar
• Souza BS, Nogueira RC, De Oliveira SA, De Freitas LA, Lyra LG, . Current status of stem cell therapy for liver diseases. Cell Transplant. 2009;18:1261–79.
   PubMed Web of Science ®Google Scholar
• Danguy A, Camby I, Kiss R. Galectins and cancer. Biochim Biophys Acta. 2002;1572:285–93.
   PubMed Web of Science ®Google Scholar
• Lyra AC, Soares MB, da Silva LF, Braga EL, . Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol. 2010;22:33–42.
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, . Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol. 2006;45:429–38.
   PubMed Web of Science ®Google Scholar
• Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. 2010;30:245–57.
   PubMed Web of Science ®Google Scholar
• Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, . Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 2005;115:56–65.
   PubMed Web of Science ®Google Scholar
• Oliveira SA, Souza BS, Guimaraes-Ferreira CA, Barreto ES, Souza SC, . Therapy with bone marrow cells reduces liver alterations in mice chronically infected by Schistosoma mansoni. World J Gastroenterol. 2008;14:5842–50.
   PubMed Web of Science ®Google Scholar
• Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, . Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 2003;422:897–901.
   PubMed Web of Science ®Google Scholar
• Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon-Walker TT, . Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration and function. Hepatology. 2011;53:2003–15.
   PubMed Web of Science ®Google Scholar
• Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci. 2002;7:793–807.
   PubMed Web of Science ®Google Scholar
• Fattouh R, Jordana M. TGF-beta, eosinophils and IL-13 in allergic airway remodeling: a critical appraisal with therapeutic considerations. Inflamm Allergy Drug Targets. 2008; 7:224–36.
   PubMedGoogle Scholar
• Rabani V, Shahsavani M, Gharavi M, Piryaei A, Azhdari Z, . Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression. Cell Biol Int. 2010;34: 601–5.
   PubMedGoogle Scholar
• Harty MW, Papa EF, Huddleston HM, Young E, Nazareth S, . Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers. Surgery. 2008;143:667–78.
   PubMedGoogle Scholar
• Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, . Scar- associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol. 2007; 178:5288–95.
   PubMed Web of Science ®Google Scholar